Physician

Weems R Pennington, MD

According to 2025 Medicare claims, Weems Pennington, MD (NPI: 1215027263) practices interventional cardiology in the Augusta-Richmond County, GA-SC market, with the plurality of this provider's patient population coming from Aiken, SC. This provider's primary affiliated billing organization is AIKEN PROFESSIONAL ASSOCIATION, LLC (NPI: 1639479801; TIN: 27-3493136) and primary practice location at 29801-6351. Pennington is affiliated with the PBACO Holding, LLC (ACO ID: A1001), participating under the MSSP model.

Pennington's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 990 traditional Medicare patients, billed 4,390 HCPCS/CPT codes, and received $324,797 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 5,273 prescription claims across 686 beneficiaries totaling $1,317,197 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 11 claims. Open Payments data shows 27 records totaling $543. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $606,459 to $324,797. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $357,241 to $1,317,197. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $7,590 and ending at $6,878.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,407	6,023	$606,459
2016	1,549	5,318	$396,902
2017	1,677	5,859	$416,831
2018	1,536	5,509	$380,695
2019	1,400	5,658	$497,424
2020	1,141	4,720	$378,468
2021	1,161	5,071	$428,876
2022	1,110	4,794	$361,659
2023	995	4,546	$341,790
2024	990	4,390	$324,797

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	576	5,579	$357,241
2016	640	6,376	$440,083
2017	658	6,088	$468,437
2018	676	6,494	$578,497
2019	722	6,346	$757,185
2020	688	5,789	$939,072
2021	717	5,423	$1,024,918
2022	699	5,294	$1,170,583
2023	687	4,961	$1,226,088
2024	686	5,273	$1,317,197

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	11	$156
2020	N/R	17	$33,551
2021	N/R	N/R	N/R
2022	N/R	24	$1,688
2023	N/R	11	$24,287
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	204	209	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	604	1,125	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	124	140	$55
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	75	75	$53
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	478	675	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	698	35,602	$679,363
Entresto	Sacubitril/Valsartan	197	9,890	$208,320
Xarelto	Rivaroxaban	140	6,993	$127,815
Repatha Sureclick	Evolocumab	53	2,662	$51,803
Jardiance	Empagliflozin	48	2,161	$41,142

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$543	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Weems R. Pennington, MD?

Tedicare shows public-source Medicare data for Weems R. Pennington, MD (NPI 1215027263), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Weems R. Pennington, MD have ACO affiliation data?

Weems R. Pennington, MD is shown with ACO affiliation data for PBACO Holding, LLC (MSSP, ACO ID A1001).

What billing organization is linked to Weems R. Pennington, MD?

Weems R. Pennington, MD is linked to AIKEN PROFESSIONAL ASSOCIATION, LLC (billing NPI 1639479801) in the available physician profile data.

Does Weems R. Pennington, MD have Open Payments data?

Weems R. Pennington, MD has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.